Effectiveness of Vaccine Chatbot on HPV Vaccine Awareness and Vaccination in China
Launched by FUDAN UNIVERSITY · Jan 26, 2024
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how an online vaccine chatbot can help increase awareness and understanding of the HPV vaccine among female middle school students and their parents in China. The main goal is to see if using this chatbot makes parents more informed about the vaccine and encourages them to vaccinate their daughters. The trial will involve two groups: one group will use the chatbot to ask questions and get instant answers about the HPV vaccine, while the other group will not use the chatbot at all. Researchers will compare the knowledge and vaccination intentions of both groups after a two-week period.
To participate, parents must have a daughter in middle school who has not yet been vaccinated against HPV and does not have any health conditions that would prevent vaccination. The students also need to be able to understand and engage with the study activities. Participants can expect to receive helpful information about the HPV vaccine through the chatbot, which they can access easily on their phones or computers. This trial is currently recruiting participants, and it's a great opportunity for parents to learn more about a vaccine that can help protect their daughters from certain cancers.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Parents of female students in middle school;
- • The students not vaccinated or appointed for HPV vaccination and without contraindications to HPV vaccines;
- • Without mental disorders or visual/reading impairments, and able to cooperate with and undergo the intervention activities;
- • Obtained informed consent and willing to participate in the study.
- Exclusion Criteria:
- • Students vaccinated or appointed for HPV vaccination or with any contraindication to HPV vaccines;
- • With mental disorders or visual/reading impairments, and unable to cooperate with and undergo the intervention activities;
- • Unwilling to participate.
About Fudan University
Fudan University, a prestigious comprehensive research university located in Shanghai, China, is committed to advancing medical science through innovative clinical research. Renowned for its rigorous academic standards and cutting-edge research facilities, Fudan University plays a pivotal role in the global health landscape by sponsoring a diverse array of clinical trials aimed at improving patient outcomes and addressing pressing medical challenges. Leveraging its multidisciplinary expertise and collaborative networks, the university strives to translate scientific discoveries into practical applications, fostering advancements in healthcare and contributing to the well-being of communities both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chizhou, Anhui, China
Shanghai, Shanghai, China
Patients applied
Trial Officials
Zhiyuan Hou, PhD
Principal Investigator
School of Public Health，Fudan University
Leesa Lin, PhD
Principal Investigator
School of Public Health, The University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported